Genera Biosystems Ltd (GBI):企業の財務・戦略的SWOT分析

◆英語タイトル:Genera Biosystems Ltd (GBI) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14492
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Genera Biosystems Ltd (GBL) is a multiplexed molecular diagnostic testing product developer. The company offers RTIplex and PapType molecular diagnostic test. Its RTIplex is a multiplexed and automated PCR based test for detection of viral and bacterial respiratory pathogens; and PapType is a molecular diagnostic test for the detection and genotyping of high risk and low risk types of human papillomavirus that cause cervical cancer or genital warts. GBL uses AmpaSand beads technology to create identifiable clusters of beads that can be distinguished in a conventional flow cytometer. The company provides products to detect influenzaA, influenzaB, influenza A H1N1, influenzaA H5N1, respiratory syncytial virus, human metapneumovirus, adenovirus, rhinovirus, bordetella pertussis, and chlamydophila pneumonia. It collaborates with pathology customers and IVD companies. GBL is headquartered in Melbourne, Victoria, Australia.

Genera Biosystems Ltd Key Recent Developments

Jan 17,2019: Genera Biosystems: Receipt of R&D tax rebate
Nov 30,2018: Genera Biosystems: changes to the board of directors
Nov 01,2018: Genera Biosystems: Quarterly cash flow & business update for 30th June 2018
May 01,2018: Genera Biosystems:Quarterly Cash Flow & Business Update

This comprehensive SWOT profile of Genera Biosystems Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Genera Biosystems Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Genera Biosystems Ltd – Key Information
Genera Biosystems Ltd – Overview
Genera Biosystems Ltd – Key Employees
Genera Biosystems Ltd – Key Employee Biographies
Genera Biosystems Ltd – Key Operational Heads
Genera Biosystems Ltd – Major Products and Services
Genera Biosystems Ltd – History
Genera Biosystems Ltd – Company Statement
Genera Biosystems Ltd – Locations And Subsidiaries
Genera Biosystems Ltd – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Genera Biosystems Ltd – Business Description
Genera Biosystems Ltd – Corporate Strategy
Genera Biosystems Ltd – SWOT Analysis
SWOT Analysis – Overview
Genera Biosystems Ltd – Strengths
Genera Biosystems Ltd – Weaknesses
Genera Biosystems Ltd – Opportunities
Genera Biosystems Ltd – Threats
Genera Biosystems Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Genera Biosystems Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Genera Biosystems Ltd, Key Information
Genera Biosystems Ltd, Key Ratios
Genera Biosystems Ltd, Share Data
Genera Biosystems Ltd, Major Products and Services
Genera Biosystems Ltd, History
Genera Biosystems Ltd, Key Employees
Genera Biosystems Ltd, Key Employee Biographies
Genera Biosystems Ltd, Key Operational Heads
Genera Biosystems Ltd, Other Locations
Genera Biosystems Ltd, Subsidiaries
Genera Biosystems Ltd, Key Manufacturing facilities
Genera Biosystems Ltd, Key Competitors
Genera Biosystems Ltd, SWOT Analysis
Genera Biosystems Ltd, Ratios based on current share price
Genera Biosystems Ltd, Annual Ratios
Genera Biosystems Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Genera Biosystems Ltd, Performance Chart
Genera Biosystems Ltd, Ratio Charts

★海外企業調査レポート[Genera Biosystems Ltd (GBI):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Grupo Financiero Galicia S.A. (GGAL3):企業の財務・戦略的SWOT分析
    Grupo Financiero Galicia S.A. (GGAL3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Omeros Corp (OMER):製薬・医療:M&Aディール及び事業提携情報
    Summary Omeros Corp (Omeros) is a biopharmaceutical company that discovers, develops and commercializes small-molecule and protein therapeutics for large-market and orphan indications. The company’s pipeline products include Omidria, a phenylephrine and ketorolac injection for use during cataract su …
  • CHC Group Ltd (HELIQ)-石油・ガス分野:企業M&A・提携分析
    Summary CHC Group Ltd. (CHC) is a commercial operator of medium and heavy helicopters that provides mission-critical services, search and rescue services, emergency and medical services, maintenance repair and overhauling services, helicopter parts sales and distribution, integrated logistics suppor …
  • CRH Medical Corp (CRH):企業の財務・戦略的SWOT分析
    Summary CRH Medical Corp (CRH Medical), is a medical device company that offers treatment of hemorrhoids. The company provides CRH O’Regan System, a hemorrhoid technology for treating hemorrhoid. It offers topical ointments and creams including preparation H for the treatment of hemorrhoid. CRH Medi …
  • Lancer Systems L.P.:企業の戦略・SWOT・財務情報
    Lancer Systems L.P. - Strategy, SWOT and Corporate Finance Report Summary Lancer Systems L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • James Fisher and Sons Plc (FSJ):石油・ガス:M&Aディール及び事業提携情報
    Summary James Fisher and Sons Plc (James Fisher) is a service provider for global marine industry and a specialist supplier of engineering services to the energy industry. The company provides comprehensive services such as design and engineering; inspection and monitoring; lifting and handling; mar …
  • Encavis AG:企業のM&A・事業提携・投資動向
    Encavis AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Encavis AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Chevron Pipe Line Co:石油・ガス:M&Aディール及び事業提携情報
    Summary Chevron Pipe Line Co (CPL), a subsidiary of Chevron Corp is an oil and gas company that operates, constructs and maintains pipeline systems for fuel transportation. The company owns and operates pipeline assets that transport refined petroleum products, liquefied petroleum gas, natural gas, …
  • Noel Gifts International Ltd. (543):企業の財務・戦略的SWOT分析
    Noel Gifts International Ltd. (543) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Pernod Ricard SA:企業の戦略・SWOT・財務情報
    Pernod Ricard SA - Strategy, SWOT and Corporate Finance Report Summary Pernod Ricard SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Reinsurance Group of America, Incorporated:戦略・SWOT・企業財務分析
    Reinsurance Group of America, Incorporated - Strategy, SWOT and Corporate Finance Report Summary Reinsurance Group of America, Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • OAO Gazprom:企業の戦略・SWOT・財務分析
    OAO Gazprom - Strategy, SWOT and Corporate Finance Report Summary OAO Gazprom - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Integrated BioTherapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Integrated BioTherapeutics Inc (IBT) is a biotechnology company that discovers novel vaccines and therapeutics for infectious diseases. The company's products include polyclonal and monoclonal antibodies raised against various emerging pathogens, vaccines and therapeutics against bacteria, p …
  • Auswide Bank Ltd (ABA):企業の財務・戦略的SWOT分析
    Auswide Bank Ltd (ABA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • CK Infrastructure Holdings Ltd (1038):石油・ガス:M&Aディール及び事業提携情報
    Summary CK Infrastructure Holdings Limited (CKI), a subsidiary of CK Hutchison Holdings Limited, is an infrastructure investment company. It holds diversified investment interests across various sectors including energy, rail transportation, water, waste management, and other infrastructure related …
  • Zynex Inc (ZYXI):医療機器:M&Aディール及び事業提携情報
    Summary Zynex Inc (Zynex), formerly Zynex Medical Inc is a medical technology company that designs, manufactures, and markets electrotherapy medical devices used for pain management and rehabilitation. The company’s products include NexWave, a dual channel, multi-modality interferential current, tra …
  • F J Benjamin Holdings Ltd.:企業の戦略・SWOT・財務情報
    F J Benjamin Holdings Ltd. - Strategy, SWOT and Corporate Finance Report Summary F J Benjamin Holdings Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Memorial Sloan Kettering Cancer Center:企業のM&A・事業提携・投資動向
    Memorial Sloan Kettering Cancer Center - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Memorial Sloan Kettering Cancer Center Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed repo …
  • 3D Oil Ltd (TDO):石油・ガス:M&Aディール及び事業提携情報
    Summary 3D Oil Ltd (3D Oil) is a producer and developer of oil and gas properties. The company’s products include natural gas and crude oil. It has interest in exploration permits in the offshore Gippsland and Otway Basins of South East Australia. 3D Oil's projects include T49-P located in offshore …
  • Korea Gas Corp (036460):企業の財務・戦略的SWOT分析
    Korea Gas Corp (036460) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆